AM Best has removed from under review with negative implications and downgraded the Financial Strength Rating to B- (Fair) from B (Fair) and the Long-Term Issuer Credit Rating to "bb-" (Fair) from
FDA Removes Partial Clinical Hold on NEON-2 Clinical Trial of Davoceticept in Combination with Pembrolizumab SEATTLE, Wash., - May 24, 2022 - Alpine Immune. | May 24, 2022
The Supreme Court on Tuesday directed the Varanasi administration to protect and seal the area where a Shivling was found, during a video survey, inside the Gyanvapi mosque complex, while also telling the authorities concerned to not restrict Muslims from entering the mosque to offer namaz.